Skip to main content
Clinical Trials/JPRN-UMIN000048307
JPRN-UMIN000048307
Recruiting
Phase 2

A prospective interventional study to evaluate the validity of sentinel node biopsy for omitting axillary dissection after neoadjuvant chemotherapy for breast cancer patients with axillary lymph node metastasis - Ganken Breast center TAD study

Cancer Institute Hospital of JFCR Breast Surgical Oncology, Breast Oncology center0 sites80 target enrollmentJuly 28, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Cancer Institute Hospital of JFCR Breast Surgical Oncology, Breast Oncology center
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 28, 2022
End Date
December 31, 2030
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cancer Institute Hospital of JFCR Breast Surgical Oncology, Breast Oncology center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • inflammatory breast cancer cases in which lymph node evaluation is difficult

Outcomes

Primary Outcomes

Not specified

Similar Trials